Full-year data also reveals an erratic recovery in terms of various media and key advertising categories.
IBM Watson Advertising today announced the availability of data from The Weather Company, an IBM Business, on the Amazon Web Services (AWS) Data Exchange.
GoodRx jointly sponsored NASCAR driver Will Rodgers, with a pharma manufacturer, creating a campaign focused on racing to cure Hepatitis C.
GoodRx launched GoodRx Health on Thursday to provide research-based answers to vital health questions.
Ad spending in the major English-speaking markets -- the U.S., the U.K., Canada, Australia, and New Zealand -- expanded 25% during the first half, including a 52% spurt during Q2, the first quarter to
reflect year-over-year comparisons with the COVID-19 ad recession of 2020, which began in March and lasted through July (based on U.S. data).
Transportation and tourism, one of the categories most severely disrupted in 2020 by the COVID-19 pandemic, is showing the greatest recovery in 2021 and 2022, according to key category growth
estimates published by WARC as part of its global ad forecast revisions. Like most of Madison Avenue's big agency forecasting units, and a variety of other independent consultants, WARC predicts
strong aggregate growth for the ad industry's recovery, with worldwide ad spending projected to expand 17.8% in 2021.
The number of ad commercial messages is flat for the week of Nov. 16-22 vs. the same week the year before for total TV ad occurrences in the top categories of automotive, insurance, pharmaceutical,
restaurants and retail. Retail has made recent improvements, down 34% in September, and 23% for October. Walmart, Target, and Macy's saw increases of 13%, 17% and 17% for the week ending Nov. 22 vs. a
year ago, while Home Depot and Lowe's are down 36% and 13%, respectively.
Trimming its Q3 declines from the steep drop in Q2, the U.S. ad market had stronger results than the U.K., Australia, and Canada, which all saw declines in digital media advertising, according to
Standard Media Index. The U.S. posted an 8% Q3 gain for digital. Pharmaceutical drugs was the strongest-performing U.S. ad category, up 19%. Automotive manufacturers and dealers were down 19%
A recent survey found 74% of consumers agreed it was appropriate for the pharma industry to keep providing branded and sponsored information and advertising related to their products during the
COVID-19 pandemic. Consumers still feel the need to stay informed by pharma companies about their choices and options independent of the COVID-19 virus.
The findings suggest Google puts consumers at risk of buying fake electronics and pharmaceutical products by glossing over web sites known to regularly feature counterfeit goods. A brand protection
company is calling on Google, Bing, Baidu, and Yandex to remove links to web sites known to routinely infringe trademarks and sell counterfeit goods.
"The sugars" is a well-known enemy, with African Americans almost twice as likely to be diagnosed with diabetes as non-Hispanic whites. An issue of this nature was a clear target for Anthony Anderson,
star of the ABC sitcom "Black-ish" and a diabetic himself.
The national U.S. ad marketplace expanded 10% in July, thanks largely to growth in key categories, such as automotive, pharma and fast-food restaurants, according to Standard Media Index. The main
media beneficiary remains digital, which grew 17% vs. July 2017.